Protecting Public Health During COVID-19

by | Apr 5, 2021 | COVID-19, Enforcement Actions, FDA, Gene and Cell Therapies, Pharmaceuticals, Recall, Regulatory, Vaccine

As we face the most challenging public health crises of our lifetimes, celebrating and thanking all those who serve public health each day is more important than ever. The American Public Health Association celebrates the week of April 5th– April 11th as National Public Health Week.1 The American Public Health Association celebrates this week to bring communities together and recognize the contributions of frontline workers to improving the nation’s public health.2

One such agency that contributes to the protection of public health is the Food and Drug Administration. The FDA through many of its initiatives and regulations ensures public health is protected at all times. Especially during the COVID-19 pandemic, the FDA and other federal agencies have been putting great efforts towards identifying and thwarting scams for products that claim they provide relief from COVID-19.

FDA’s dedicated COVID-19 Fraudulent Products Task Force has identified nearly 1300 fraudulent products, has issued more than 160 warning letters, more than 270 abuse complaints to domain registrars, and has sent more than 290 requests to remove listings of fraudulent products on various web-based marketplaces.3

FDA has established various communications channels for consumers to protect themselves and seek FDA’s help to take appropriate action against such companies. Consumers can easily submit reports of fraudulent, unauthorized, or unapproved products on the market to the FDA via its website and this, in turn, helps FDA to protect public health.

EMMA International recognizes the importance of the FDA and the role it plays in protecting public health. If you are a manufacturer and want to ensure your product meets the FDA’s requirements of safety and efficacy we are here to help!

Call us today at 248-987-4497 or email us at to learn more about our services.

1National Public Health Week (2021) See you soon for National Public Health Week 2021! Retrieved on 04/04/2021 from

2APHA (2021) National Public Health Week retrieved on 04/04/2021 from

3FDA (2021) National Consumer Protection Week: FDA Is Vigilant in Protecting Consumers Against COVID-19 Vaccine Scams retrieved on 04/04/2021 from

Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This